top of page

Patient recruitment starts for MERS vaccine trial

Inovio has begun recruitment for its collaborative vaccine study for Middle East Respiratory Syndrome (MERS). Inovio and GeneOne Life Science are co-developing Inovio’s MERS vaccine (GLS-5300) in partnership with the Walter Reed Army Institute of Research (WRAIR) in Maryland, where the trial is being conducted. Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page